Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation

被引:43
作者
Wulffraat, NM
Haas, PJ
Frosch, M
de Kleer, IM
Vogl, T
Brinkman, DMC
Quartier, P
Roth, J
Kuis, W
机构
[1] Univ Utrecht, Wilhelmina Childrens Hosp, Med Ctr, Dept Paediat Immunol, Utrecht, Netherlands
[2] Univ Munster, Dept Paediat, Munster, Germany
[3] Univ Munster, Inst Expt Dermatol, Munster, Germany
[4] Leiden Univ, Med Ctr, Dept Paediat, Leiden, Netherlands
[5] Hop Necker Enfants Malad, Dept Paediat Immunol Haematol & Rheumatol, Paris, France
关键词
D O I
10.1136/ard.62.3.236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine whether myeloid related proteins (MRP8/MRP 14), a complex of two S 100 proteins related to neutrophil and monocyte activation, might be used as a marker for disease activity, and as an early indicator of relapse in juvenile idiopathic arthritis. Patients and methods: A group of 12 patients who underwent an autologous haematopoietic stem cell transplantation (ASCT) for refractory juvenile idiopathic arthritis (JIA) were studied. MRP8/MRP14 serum concentrations were determined by a sandwich enzyme linked immunosorbent assay (ELISA) as described. Improvement from baseline was described by a definition of improvement employing a core set of criteria as detailed previously by Giannini. Results: After ASCT, MRP8/MRP 14 serum concentrations in JIA showed a positive correlation with the Child Health Assessment Questionnaire (CHAQ; r = 0.80) and erythrocyte sedimentation rate (r = 0.45), but not with the total leucocyte count (r = 0.26). Mean MRP8/MRP 14 serum concentrations dropped markedly in the first three months after ASCT (p = 0.0039) and clinical parameters of disease activity such as CHAQ markedly improved (p = 0.0039). During a transient relapse there was an increase in MRP8/MRP14. Conclusions: MRP8/MRP14 serum concentration can be used as a marker for disease activity in patients who receive an ASCT for refractory JIA. This indicates a role of macrophage activation in the pathogenesis of JIA. The occurrence of MAS in three patients in this study was not preceded by significant changes in MRP8/MRP 14 concentration.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 32 条
[1]  
BROOKS PM, 1995, J RHEUMATOL, V22, P1809
[2]   Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study [J].
Fassas, A ;
Anagnostopoulos, A ;
Kazis, A ;
Kapinas, K ;
Sakellari, I ;
Kimiskidis, V ;
Tsompanakou, A .
BONE MARROW TRANSPLANTATION, 1997, 20 (08) :631-638
[3]  
Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO
[4]  
2-X
[5]   REDUCED JOINT COUNTS IN CONTROLLED CLINICAL-TRIALS IN RHEUMATOID-ARTHRITIS [J].
FUCHS, HA ;
PINCUS, T .
ARTHRITIS AND RHEUMATISM, 1994, 37 (04) :470-475
[6]  
Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202
[7]  
Grom AA, 1996, J PEDIATR-US, V129, P630
[8]   IDENTIFICATION AND CHARACTERIZATION OF A NOVEL HUMAN NEUTROPHIL PROTEIN RELATED TO THE S100 FAMILY [J].
GUIGNARD, F ;
MAUEL, J ;
MARKERT, M .
BIOCHEMICAL JOURNAL, 1995, 309 :395-401
[9]   Autologous bone-marrow transplantation for rheumatoid arthritis [J].
Joske, DJL .
LANCET, 1997, 350 (9074) :337-338
[10]  
LEMARCHAND P, 1992, J BIOL CHEM, V267, P19379